Skip to main content
. 2022 Sep 30;115(2):188–204. doi: 10.1002/bdr2.2091

TABLE 3.

Pregnancy and infant outcomes in evaluable participants with confirmed pregnancy outcomes within the BPR cohort (overall prospective cohort; N = 55 pregnancies)

Outcomes Prospective cohort
Pregnancy outcomes, n (%) N = 55 pregnancies
Live birth 53 (96)
Miscarriage 2 (4)
Molar pregnancy 0
Ectopic pregnancy 0
Elective termination 0
Stillbirth 0
Infant outcomes
At birth, n (%) N = 56 infants
Pre‐term birth a 16 (29)
Neonatal death 0
SGA b 4 (7)
SGA c 11 (20)
At 4 months, n (%) N = 46 infants
Infants with at least one infection or fever d 6 (13)
Developmental milestone delayed by type e
Gross motor 1 (2)
Fine motor 0
Cognitive 0
Socio‐emotional 0
Language 0
At 12 months, n (%) N = 43 infants
Infants with at least one infection or fever d 14 (33)
Developmental milestone delayed by type e
Gross motor 2 (5)
Fine motor 1 (2)
Cognitive 0
Socio‐emotional 1 (2)
Language 2 (5)

Abbreviations: ACOG, American College of Obstetricians and Gynecologists; BPR, Belimumab Pregnancy Registry; INTERGROWTH‐21st, International Fetal and Newborn Growth Consortium for the 21st Century; SGA, small for gestational age.

a

Includes infants from two sets of twins;

b

INTERGROWTH‐21st criteria;

c

ACOG criteria;

d

Any infection or fever of “unknown origin” or “of known infectious etiology that occurs through three months of age for an infant”;

e

Provided by the pediatrician and combined across gross motor, fine motor, cognitive, socio‐emotional, and language milestones for cases where this information was available.